Form 4: Omnicell Director Robin Seim Receives Stock Grant

Omnicell, Inc. reports a stock grant to Director Robin Gene Seim, with shares vesting one year from the grant date.

Summary

• Director Robin Gene Seim was granted 4,845 shares of Omnicell, Inc. common stock on June 1, 2026.
• This grant is part of the Issuer's equity incentive plan and compensation for services as a Board Member.
• The shares are subject to vesting, with full vesting occurring on the one-year anniversary of the grant date.
• Following this transaction, Robin Gene Seim beneficially owns 52,198 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director as part of their compensation, rather than a significant strategic event or financial performance indicator.

Positives

• Director compensation through equity incentive plans aligns management and board interests with shareholders.
• The grant of 4,845 shares indicates continued investment in the company's leadership.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the technology and healthcare sectors, where Omnicell operates, to attract and retain talent and align incentives with long-term company performance.

Stakeholder Impact

• Shareholders: The grant aligns director interests with long-term shareholder value through equity ownership.
• Employees: This filing is a standard disclosure and does not directly impact employees.
• Creditors: No direct impact on creditors.
• Suppliers: No direct impact on suppliers.

Next Steps

• The granted shares will vest in full on the one-year anniversary of the grant date.

Key Dates

Keywords

Omnicell, OMCL, Form 4, Stock Grant, Director Compensation, Equity Incentive Plan, Beneficial Ownership, Robin Gene Seim